Presentation of lipoteichoic acid potentiates its inflammatory activity

被引:30
作者
Deininger, Susanne [1 ]
Traub, Stephanie [1 ]
Aichele, Diana [1 ]
Rupp, Tamara [1 ]
Baris, Teodora [1 ]
Moeller, Heiko M. [2 ]
Hartung, Thomas [1 ,3 ]
von Aulock, Sonja [1 ]
机构
[1] Univ Konstanz, D-78464 Constance, Germany
[2] Univ Konstanz, Dept Chem, D-78464 Constance, Germany
[3] Joint Res Ctr, European Ctr Validation Alternat Methods, I-21021 Ispra, Italy
关键词
bacteria; cytokines; inflammation; lipoteichoic acid; potency;
D O I
10.1016/j.imbio.2008.01.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Lipoteichoic acid (LTA) is a major immunostimulatory molecule in the cell wall of Gram-positive bacteria. Adhesion of LTA to a polystyrene surface drastically increased its immunostimulatory potency in human whole blood in comparison to soluble LTA, although only 1% of the LTA had bound, as determined using rhodamine-labelled LTA. The release of the proinflammatory cytokines IL-1 beta, TNF and IL-6 and the chemokines IL-8 and G-CSF was increased 2- to 10-fold, but IL-10 release was unaltered. This presentation effect was not shared by lipopolysaccharide (LPS) or other toll-like receptor 2 agonists and was less pronounced in polypropylene vessels. LTA did not induce cytokine release in silicone-coated borosilicate vessels, but covalent coupling of LTA to polypropylene beads restored cytokine induction in these vessels, indicating that presentation of LTA on a surface is in fact essential for its immunostimulatory potency. This novel aspect of presentation as a factor in the recognition of LTA may reflect the physiological situation in the bacterial cell wall, where LTA is anchored in the bacterial membrane and projects through the peptidoglycan. In practical terms, contamination of medical devices with components of Gram-positive bacteria may pose an understimated inflammatory risk. (C) 2008 Elsevier GmbH. All rights reserved.
引用
收藏
页码:519 / 529
页数:11
相关论文
共 31 条
[1]
AASJORD P, 1980, ACTA PATH MICRO IM B, V88, P47
[2]
A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages [J].
Brightbill, HD ;
Plevy, SE ;
Modlin, RL ;
Smale, ST .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1940-1951
[3]
Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives [J].
Deininger, S ;
Stadelmaier, A ;
von Aulock, S ;
Morath, S ;
Schmidt, RR ;
Hartung, T .
JOURNAL OF IMMUNOLOGY, 2003, 170 (08) :4134-4138
[4]
Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae [J].
Draing, Christian ;
Pfitzenmaier, Markus ;
Zummo, Sebastiana ;
Mancuso, Giuseppe ;
Geyer, Armin ;
Hartung, Thomas ;
von Aulock, Sonja .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (45) :33849-33859
[5]
Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro [J].
Gao, JJ ;
Xue, Q ;
Zuvanich, EG ;
Haghi, KR ;
Morrison, DC .
INFECTION AND IMMUNITY, 2001, 69 (02) :751-757
[6]
Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2 [J].
Han, SH ;
Kim, JH ;
Seo, HS ;
Martin, MH ;
Chung, GH ;
Michalek, SM ;
Nahm, MH .
JOURNAL OF IMMUNOLOGY, 2006, 176 (01) :573-579
[7]
Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO
[8]
2-P
[9]
CD36 is a sensor of diacylglycerides [J].
Hoebe, K ;
Georgel, P ;
Rutschmann, S ;
Du, X ;
Mudd, S ;
Crozat, K ;
Sovath, S ;
Shamel, L ;
Hartung, T ;
Zähringer, U ;
Beutler, B .
NATURE, 2005, 433 (7025) :523-527
[10]
MOLECULES FROM STAPHYLOCOCCUS-AUREUS THAT BIND CD14 AND STIMULATE INNATE IMMUNE-RESPONSES [J].
KUSUNOKI, T ;
HAILMAN, E ;
JUAN, TSC ;
LICHENSTEIN, HS ;
WRIGHT, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1673-1682